× Industry Reports Services Press Release Contact us About us

Europe Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Industry Analysis Report, Regional Outlook (Germany, UK, France, Spain, Italy, Russia, Ukraine, Poland, Switzerland, Belgium, Greece, Czech Republic, Netherlands, Sweden), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Published Date: September 2018 | Publisher: Graphical Research Report ID: GR1066 | Delivery : PDF

Report Content    
Chapter 1.    Methodology 
1.1.    Methodology
1.2.    Market definitions
1.3.    Forecast parameters
1.4.    Data sources
1.4.1.    Secondary
1.4.1.1.    Paid sources
1.4.1.2.    Unpaid sources    
1.4.2.    Primary 
Chapter 2.    Executive Summary
2.1.    Europe cell line development market industry 3600 synopsis, 2013 – 2024
Chapter 3.    Europe Cell Line Development Industry Insights
3.1.    Industry segmentation
3.2.    Industry landscape, 2013 – 2024
3.3.    Industry impact forces
3.3.1.    Growth drivers
3.3.1.1.    Growing vaccine production
3.3.1.2.    Increasing number of cancer incidences
3.3.1.3.    Extended applications of biotechnology sector
3.3.1.4.    Patent expiration of blockbuster biologics leading to innovations in the field
3.3.1.5.    Escalating demand for monoclonal antibodies in Europe
3.3.1.6.    Technological advancements in cell line development
3.3.2.    Industry pitfalls & challenges
3.3.2.1.    Growing concerns related to stem cell research
3.4.    Growth potential analysis
3.4.1.    By product
3.4.2.    By source
3.4.3.    By cell-line type
3.4.4.    By application
3.5.    Competitive landscape, 2017
3.5.1.    Strategy dashboard
3.6.    Porter’s analysis
3.7.    PESTEL analysis
Chapter 4.    Europe Cell Line Development Market, By Product
4.1.    Key segment trends
4.2.    Reagents and media
4.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
4.3.    Equipment
4.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.2.    Incubators
4.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.3.    Centrifuges
4.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.4.    Bioreactors
4.3.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.5.    Storage equipment
4.3.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.6.    Microscopes
4.3.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.4.    Accessories
4.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 5.    Europe Cell Line Development Market, By Source
5.1.    Key segment trends
5.2.    Mammalian
5.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.    Non-mammalian
5.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.2.    Insects
5.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.3.    Amphibians
5.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
Chapter 6.    Europe Cell Line Development Market, By Cell Line Type
6.1.    Key segment trends
6.2.    Recombinant cell lines
6.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.3.    Hybridomas
6.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.4.    Continuous cell lines
6.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.5.    Primary cell lines
6.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 7.    Europe Cell Line Development Market, By Application
7.1.    Key segment trends
7.2.    Bioproduction
7.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.3.    Drug discovery
7.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.4.    Toxicity testing
7.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.5.    Tissue engineering
7.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.6.    Research
7.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 8.    Europe Cell Line Development Market, By Country
8.1.    Key regional trends
8.2.    Europe
8.2.1.    Market size by country, 2013 – 2024(USD Million)
8.2.2.    Market size by product, 2013 – 2024(USD Million)    
8.2.3.    Market size by source, 2013 – 2024(USD Million)
8.2.4.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.5.    Market size by application, 2013 – 2024(USD Million)
8.2.6.    Germany
8.2.6.1.    Market size by product, 2013 – 2024(USD Million)
8.2.6.2.    Market size by source, 2013 – 2024(USD Million)
8.2.6.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.6.4.    Market size by application, 2013 – 2024(USD Million)
8.2.7.    UK
8.2.7.1.    Market size by product, 2013 – 2024(USD Million)
8.2.7.2.    Market size by source, 2013 – 2024(USD Million)
8.2.7.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.7.4.    Market size by application, 2013 – 2024(USD Million)
8.2.8.    France
8.2.8.1.    Market size by product, 2013 – 2024(USD Million)
8.2.8.2.    Market size by source, 2013 – 2024(USD Million)
8.2.8.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.8.4.    Market size by application, 2013 – 2024(USD Million)
8.2.9.    Italy
8.2.9.1.    Market size by product, 2013 – 2024(USD Million)
8.2.9.2.    Market size by source, 2013 – 2024(USD Million)
8.2.9.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.9.4.    Market size by application, 2013 – 2024(USD Million)
8.2.10.    Spain
8.2.10.1.    Market size by product, 2013 – 2024(USD Million)
8.2.10.2.    Market size by source, 2013 – 2024(USD Million)
8.2.10.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.10.4.    Market size by application, 2013 – 2024(USD Million)
8.2.11.    Russia
8.2.11.1.    Market size by product, 2013 – 2024(USD Million)
8.2.11.2.    Market size by source, 2013 – 2024(USD Million)
8.2.11.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.11.4.    Market size by application, 2013 – 2024(USD Million)
8.2.12.    Ukraine
8.2.12.1.    Market size by product, 2013 – 2024(USD Million)
8.2.12.2.    Market size by source, 2013 – 2024(USD Million)
8.2.12.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.12.4.    Market size by application, 2013 – 2024(USD Million)
8.2.13.    Poland
8.2.13.1.    Market size by product, 2013 – 2024(USD Million)
8.2.13.2.    Market size by source, 2013 – 2024(USD Million)
8.2.13.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.13.4.    Market size by application, 2013 – 2024(USD Million)
8.2.14.    Switzerland
8.2.14.1.    Market size by product, 2013 – 2024(USD Million)
8.2.14.2.    Market size by source, 2013 – 2024(USD Million)
8.2.14.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.14.4.    Market size by application, 2013 – 2024(USD Million)
8.2.15.    Belgium
8.2.15.1.    Market size by product, 2013 – 2024(USD Million)
8.2.15.2.    Market size by source, 2013 – 2024(USD Million)
8.2.15.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.15.4.    Market size by application, 2013 – 2024(USD Million)
8.2.16.    Greece
8.2.16.1.    Market size by product, 2013 – 2024(USD Million)
8.2.16.2.    Market size by source, 2013 – 2024(USD Million)
8.2.16.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.16.4.    Market size by application, 2013 – 2024(USD Million)
8.2.17.    Czech Republic
8.2.17.1.    Market size by product, 2013 – 2024(USD Million)
8.2.17.2.    Market size by source, 2013 – 2024(USD Million)
8.2.17.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.17.4.    Market size by application, 2013 – 2024(USD Million)
8.2.18.    Netherlands
8.2.18.1.    Market size by product, 2013 – 2024(USD Million)
8.2.18.2.    Market size by source, 2013 – 2024(USD Million)
8.2.18.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.18.4.    Market size by application, 2013 – 2024(USD Million)
8.2.19.    Sweden
8.2.19.1.    Market size by product, 2013 – 2024(USD Million)
8.2.19.2.    Market size by source, 2013 – 2024(USD Million)
8.2.19.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.19.4.    Market size by application, 2013 – 2024(USD Million)
Chapter 9.    Company Profiles
9.1.    GE Healthcare
9.1.1.    Business overview
9.1.2.    Financial data
9.1.3.    Product landscape
9.1.4.    Strategic outlook
9.1.5.    SWOT analysis
9.2.    Thermo Fisher Scientific Inc.
9.2.1.    Business overview
9.2.2.    Financial data
9.2.3.    Product landscape
9.2.4.    Strategic outlook
9.2.5.    SWOT analysis
9.3.    Lonza Group AG
9.3.1.    Business overview
9.3.2.    Financial data
9.3.3.    Product landscape
9.3.4.    Strategic outlook
9.3.5.    SWOT analysis
9.4.    Sigma-Aldrich Corporation (Merck)
9.4.1.    Business overview
9.4.2.    Financial data
9.4.3.    Product landscape
9.4.4.    Strategic outlook
9.4.5.    SWOT analysis
9.5.    WuXi AppTec
9.5.1.    Business overview
9.5.2.    Financial data
9.5.3.    Product landscape
9.5.4.    Strategic outlook
9.5.5.    SWOT analysis
9.6.    Sartorius Stedim Biotech GmbH
9.6.1.    Business overview
9.6.2.    Financial data
9.6.3.    Product landscape
9.6.4.    Strategic outlook
9.6.5.    SWOT analysis
9.7.    Vista Biologicals Co.
9.7.1.    Business overview
9.7.2.    Financial data
9.7.3.    Product landscape
9.7.4.    Strategic outlook
9.7.5.    SWOT analysis
9.8.    The European Collection of Cell Cultures
9.8.1.    Business overview
9.8.2.    Financial data
9.8.3.    Product landscape
9.8.4.    Strategic outlook
9.8.5.    SWOT analysis
9.9.    GVK BIO
9.9.1.    Business overview
9.9.2.    Financial data
9.9.3.    Product landscape
9.9.4.    Strategic outlook
9.9.5.    SWOT analysis
9.10.    Progenitor Cell Therapy (PCT)
9.10.1.    Business overview
9.10.2.    Financial data
9.10.3.    Product landscape
9.10.4.    Strategic outlook
9.10.5.    SWOT analysis
9.11.    Selexis SA
9.11.1.    Business overview
9.11.2.    Financial data
9.11.3.    Product landscape
9.11.4.    Strategic outlook
9.11.5.    SWOT analysis
Data Tables
TABLE 1.    Europe cell line development industry 3600 synopsis, 2013 – 2024
TABLE 2.    Industry impact forces
TABLE 3.    Reagents and media market size, by country, 2013 – 2024 (USD Mn)
TABLE 4.    Cell line development equipment market size, by country, 2013 – 2024 (USD Mn)
TABLE 5.    Incubators market size, by country, 2013 – 2024 (USD Mn)
TABLE 6.    Centrifuges market size, by country, 2013 – 2024 (USD Mn)
TABLE 7.    Bioreactors market size, by country, 2013 – 2024 (USD Mn)
TABLE 8.    Storage equipment market size, by country, 2013 – 2024 (USD Mn)
TABLE 9.    Microscopes market size, by country, 2013 – 2024 (USD Mn)
TABLE 10.    Cell line development accessories market size, by country, 2013 – 2024 (USD Mn)
TABLE 11.    Mammalian cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 12.    Non-mammalian cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 13.    Non-mammalian insects cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 14.    Non-mammalian amphibians cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 15.    Recombinant cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 16.    Hybridomas market size, by country, 2013 – 2024 (USD Mn)
TABLE 17.    Continuous cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 18.    Primary cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 19.    Bioproduction market size, by country, 2013 – 2024 (USD Mn)
TABLE 20.    Drug discovery market size, by country, 2013 – 2024 (USD Mn)
TABLE 21.    Toxicity testing market size, by country, 2013 – 2024 (USD Mn)
TABLE 22.    Tissue engineering market size, by country, 2013 – 2024 (USD Mn)
TABLE 23.    Research market size, by country, 2013 – 2024 (USD Mn)
TABLE 24.    Europe cell line development market, by country 2013 - 2024 (USD Mn)
TABLE 25.    Europe cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 26.    Europe cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 27.    Europe cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 28.    Europe cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 29.    Europe cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 30.    Europe cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 31.    Germany cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 32.    Germany cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 33.    Germany cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 34.    Germany cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 35.    Germany cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 36.    Germany cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 37.    France cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 38.    France cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 39.    France cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 40.    France cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 41.    France cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 42.    France cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 43.    UK cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 44.    UK cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 45.    UK cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 46.    UK cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 47.    UK cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 48.    UK cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 49.    Spain cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 50.    Spain cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 51.    Spain cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 52.    Spain cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 53.    Spain cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 54.    Spain cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 55.    Italy cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 56.    Italy cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 57.    Italy cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 58.    Italy cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 59.    Italy cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 60.    Italy cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 61.    Russia cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 62.    Russia cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 63.    Russia cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 64.    Russia cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 65.    Russia cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 66.    Russia cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 67.    Ukraine cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 68.    Ukraine cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 69.    Ukraine cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 70.    Ukraine cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 71.    Ukraine cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 72.    Ukraine cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 73.    Poland cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 74.    Poland cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 75.    Poland cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 76.    Poland cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 77.    Poland cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 78.    Poland cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 79.    Switzerland cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 80.    Switzerland cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 81.    Switzerland cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 82.    Switzerland cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 83.    Switzerland cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 84.    Switzerland cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 85.    Belgium cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 86.    Belgium cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 87.    Belgium cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 88.    Belgium cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 89.    Belgium cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 90.    Belgium cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 91.    Greece cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 92.    Greece cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 93.    Greece cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 94.    Greece cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 95.    Greece cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 96.    Greece cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 97.    Czech Republic cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 98.    Czech Republic cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 99.    Czech Republic cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 100.    Czech Republic cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 101.    Czech Republic cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 102.    Czech Republic cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 103.    Netherlands cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 104.    Netherlands cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 105.    Netherlands cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 106.    Netherlands cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 107.    Netherlands cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 108.    Netherlands cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 109.    Sweden cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 110.    Sweden cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 111.    Sweden cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 112.    Sweden cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 113.    Sweden cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 114.    Sweden cell line development market, by application, 2013 - 2024 (USD Mn)

Charts & Figures
FIG 1.    Industry segmentation
FIG 2.    Europe cell line development market, 2013 - 2024 (USD Million)
FIG 3.    Growth potential analysis, by product
FIG 4.    Growth potential analysis, by source
FIG 5.    Growth potential analysis, by cell line type
FIG 6.    Growth potential analysis, by application
FIG 7.    Strategy dashboard
FIG 8.    Porter’s analysis
FIG 9.    PESTEL analysis
 

Report Content    
Chapter 1.    Methodology 
1.1.    Methodology
1.2.    Market definitions
1.3.    Forecast parameters
1.4.    Data sources
1.4.1.    Secondary
1.4.1.1.    Paid sources
1.4.1.2.    Unpaid sources    
1.4.2.    Primary 
Chapter 2.    Executive Summary
2.1.    Europe cell line development market industry 3600 synopsis, 2013 – 2024
Chapter 3.    Europe Cell Line Development Industry Insights
3.1.    Industry segmentation
3.2.    Industry landscape, 2013 – 2024
3.3.    Industry impact forces
3.3.1.    Growth drivers
3.3.1.1.    Growing vaccine production
3.3.1.2.    Increasing number of cancer incidences
3.3.1.3.    Extended applications of biotechnology sector
3.3.1.4.    Patent expiration of blockbuster biologics leading to innovations in the field
3.3.1.5.    Escalating demand for monoclonal antibodies in Europe
3.3.1.6.    Technological advancements in cell line development
3.3.2.    Industry pitfalls & challenges
3.3.2.1.    Growing concerns related to stem cell research
3.4.    Growth potential analysis
3.4.1.    By product
3.4.2.    By source
3.4.3.    By cell-line type
3.4.4.    By application
3.5.    Competitive landscape, 2017
3.5.1.    Strategy dashboard
3.6.    Porter’s analysis
3.7.    PESTEL analysis
Chapter 4.    Europe Cell Line Development Market, By Product
4.1.    Key segment trends
4.2.    Reagents and media
4.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
4.3.    Equipment
4.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.2.    Incubators
4.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.3.    Centrifuges
4.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.4.    Bioreactors
4.3.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.5.    Storage equipment
4.3.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.3.6.    Microscopes
4.3.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
4.4.    Accessories
4.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 5.    Europe Cell Line Development Market, By Source
5.1.    Key segment trends
5.2.    Mammalian
5.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.    Non-mammalian
5.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.2.    Insects
5.3.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
5.3.3.    Amphibians
5.3.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)    
Chapter 6.    Europe Cell Line Development Market, By Cell Line Type
6.1.    Key segment trends
6.2.    Recombinant cell lines
6.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.3.    Hybridomas
6.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.4.    Continuous cell lines
6.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
6.5.    Primary cell lines
6.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 7.    Europe Cell Line Development Market, By Application
7.1.    Key segment trends
7.2.    Bioproduction
7.2.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.3.    Drug discovery
7.3.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.4.    Toxicity testing
7.4.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.5.    Tissue engineering
7.5.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
7.6.    Research
7.6.1.    Market estimates and forecast, by country, 2013 – 2024 (USD Million)
Chapter 8.    Europe Cell Line Development Market, By Country
8.1.    Key regional trends
8.2.    Europe
8.2.1.    Market size by country, 2013 – 2024(USD Million)
8.2.2.    Market size by product, 2013 – 2024(USD Million)    
8.2.3.    Market size by source, 2013 – 2024(USD Million)
8.2.4.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.5.    Market size by application, 2013 – 2024(USD Million)
8.2.6.    Germany
8.2.6.1.    Market size by product, 2013 – 2024(USD Million)
8.2.6.2.    Market size by source, 2013 – 2024(USD Million)
8.2.6.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.6.4.    Market size by application, 2013 – 2024(USD Million)
8.2.7.    UK
8.2.7.1.    Market size by product, 2013 – 2024(USD Million)
8.2.7.2.    Market size by source, 2013 – 2024(USD Million)
8.2.7.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.7.4.    Market size by application, 2013 – 2024(USD Million)
8.2.8.    France
8.2.8.1.    Market size by product, 2013 – 2024(USD Million)
8.2.8.2.    Market size by source, 2013 – 2024(USD Million)
8.2.8.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.8.4.    Market size by application, 2013 – 2024(USD Million)
8.2.9.    Italy
8.2.9.1.    Market size by product, 2013 – 2024(USD Million)
8.2.9.2.    Market size by source, 2013 – 2024(USD Million)
8.2.9.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.9.4.    Market size by application, 2013 – 2024(USD Million)
8.2.10.    Spain
8.2.10.1.    Market size by product, 2013 – 2024(USD Million)
8.2.10.2.    Market size by source, 2013 – 2024(USD Million)
8.2.10.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.10.4.    Market size by application, 2013 – 2024(USD Million)
8.2.11.    Russia
8.2.11.1.    Market size by product, 2013 – 2024(USD Million)
8.2.11.2.    Market size by source, 2013 – 2024(USD Million)
8.2.11.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.11.4.    Market size by application, 2013 – 2024(USD Million)
8.2.12.    Ukraine
8.2.12.1.    Market size by product, 2013 – 2024(USD Million)
8.2.12.2.    Market size by source, 2013 – 2024(USD Million)
8.2.12.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.12.4.    Market size by application, 2013 – 2024(USD Million)
8.2.13.    Poland
8.2.13.1.    Market size by product, 2013 – 2024(USD Million)
8.2.13.2.    Market size by source, 2013 – 2024(USD Million)
8.2.13.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.13.4.    Market size by application, 2013 – 2024(USD Million)
8.2.14.    Switzerland
8.2.14.1.    Market size by product, 2013 – 2024(USD Million)
8.2.14.2.    Market size by source, 2013 – 2024(USD Million)
8.2.14.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.14.4.    Market size by application, 2013 – 2024(USD Million)
8.2.15.    Belgium
8.2.15.1.    Market size by product, 2013 – 2024(USD Million)
8.2.15.2.    Market size by source, 2013 – 2024(USD Million)
8.2.15.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.15.4.    Market size by application, 2013 – 2024(USD Million)
8.2.16.    Greece
8.2.16.1.    Market size by product, 2013 – 2024(USD Million)
8.2.16.2.    Market size by source, 2013 – 2024(USD Million)
8.2.16.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.16.4.    Market size by application, 2013 – 2024(USD Million)
8.2.17.    Czech Republic
8.2.17.1.    Market size by product, 2013 – 2024(USD Million)
8.2.17.2.    Market size by source, 2013 – 2024(USD Million)
8.2.17.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.17.4.    Market size by application, 2013 – 2024(USD Million)
8.2.18.    Netherlands
8.2.18.1.    Market size by product, 2013 – 2024(USD Million)
8.2.18.2.    Market size by source, 2013 – 2024(USD Million)
8.2.18.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.18.4.    Market size by application, 2013 – 2024(USD Million)
8.2.19.    Sweden
8.2.19.1.    Market size by product, 2013 – 2024(USD Million)
8.2.19.2.    Market size by source, 2013 – 2024(USD Million)
8.2.19.3.    Market size by cell line type, 2013 – 2024(USD Million)
8.2.19.4.    Market size by application, 2013 – 2024(USD Million)
Chapter 9.    Company Profiles
9.1.    GE Healthcare
9.1.1.    Business overview
9.1.2.    Financial data
9.1.3.    Product landscape
9.1.4.    Strategic outlook
9.1.5.    SWOT analysis
9.2.    Thermo Fisher Scientific Inc.
9.2.1.    Business overview
9.2.2.    Financial data
9.2.3.    Product landscape
9.2.4.    Strategic outlook
9.2.5.    SWOT analysis
9.3.    Lonza Group AG
9.3.1.    Business overview
9.3.2.    Financial data
9.3.3.    Product landscape
9.3.4.    Strategic outlook
9.3.5.    SWOT analysis
9.4.    Sigma-Aldrich Corporation (Merck)
9.4.1.    Business overview
9.4.2.    Financial data
9.4.3.    Product landscape
9.4.4.    Strategic outlook
9.4.5.    SWOT analysis
9.5.    WuXi AppTec
9.5.1.    Business overview
9.5.2.    Financial data
9.5.3.    Product landscape
9.5.4.    Strategic outlook
9.5.5.    SWOT analysis
9.6.    Sartorius Stedim Biotech GmbH
9.6.1.    Business overview
9.6.2.    Financial data
9.6.3.    Product landscape
9.6.4.    Strategic outlook
9.6.5.    SWOT analysis
9.7.    Vista Biologicals Co.
9.7.1.    Business overview
9.7.2.    Financial data
9.7.3.    Product landscape
9.7.4.    Strategic outlook
9.7.5.    SWOT analysis
9.8.    The European Collection of Cell Cultures
9.8.1.    Business overview
9.8.2.    Financial data
9.8.3.    Product landscape
9.8.4.    Strategic outlook
9.8.5.    SWOT analysis
9.9.    GVK BIO
9.9.1.    Business overview
9.9.2.    Financial data
9.9.3.    Product landscape
9.9.4.    Strategic outlook
9.9.5.    SWOT analysis
9.10.    Progenitor Cell Therapy (PCT)
9.10.1.    Business overview
9.10.2.    Financial data
9.10.3.    Product landscape
9.10.4.    Strategic outlook
9.10.5.    SWOT analysis
9.11.    Selexis SA
9.11.1.    Business overview
9.11.2.    Financial data
9.11.3.    Product landscape
9.11.4.    Strategic outlook
9.11.5.    SWOT analysis
Data Tables
TABLE 1.    Europe cell line development industry 3600 synopsis, 2013 – 2024
TABLE 2.    Industry impact forces
TABLE 3.    Reagents and media market size, by country, 2013 – 2024 (USD Mn)
TABLE 4.    Cell line development equipment market size, by country, 2013 – 2024 (USD Mn)
TABLE 5.    Incubators market size, by country, 2013 – 2024 (USD Mn)
TABLE 6.    Centrifuges market size, by country, 2013 – 2024 (USD Mn)
TABLE 7.    Bioreactors market size, by country, 2013 – 2024 (USD Mn)
TABLE 8.    Storage equipment market size, by country, 2013 – 2024 (USD Mn)
TABLE 9.    Microscopes market size, by country, 2013 – 2024 (USD Mn)
TABLE 10.    Cell line development accessories market size, by country, 2013 – 2024 (USD Mn)
TABLE 11.    Mammalian cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 12.    Non-mammalian cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 13.    Non-mammalian insects cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 14.    Non-mammalian amphibians cell line development market size, by country, 2013 – 2024 (USD Mn)
TABLE 15.    Recombinant cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 16.    Hybridomas market size, by country, 2013 – 2024 (USD Mn)
TABLE 17.    Continuous cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 18.    Primary cell lines market size, by country, 2013 – 2024 (USD Mn)
TABLE 19.    Bioproduction market size, by country, 2013 – 2024 (USD Mn)
TABLE 20.    Drug discovery market size, by country, 2013 – 2024 (USD Mn)
TABLE 21.    Toxicity testing market size, by country, 2013 – 2024 (USD Mn)
TABLE 22.    Tissue engineering market size, by country, 2013 – 2024 (USD Mn)
TABLE 23.    Research market size, by country, 2013 – 2024 (USD Mn)
TABLE 24.    Europe cell line development market, by country 2013 - 2024 (USD Mn)
TABLE 25.    Europe cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 26.    Europe cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 27.    Europe cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 28.    Europe cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 29.    Europe cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 30.    Europe cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 31.    Germany cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 32.    Germany cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 33.    Germany cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 34.    Germany cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 35.    Germany cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 36.    Germany cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 37.    France cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 38.    France cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 39.    France cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 40.    France cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 41.    France cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 42.    France cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 43.    UK cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 44.    UK cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 45.    UK cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 46.    UK cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 47.    UK cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 48.    UK cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 49.    Spain cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 50.    Spain cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 51.    Spain cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 52.    Spain cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 53.    Spain cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 54.    Spain cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 55.    Italy cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 56.    Italy cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 57.    Italy cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 58.    Italy cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 59.    Italy cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 60.    Italy cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 61.    Russia cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 62.    Russia cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 63.    Russia cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 64.    Russia cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 65.    Russia cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 66.    Russia cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 67.    Ukraine cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 68.    Ukraine cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 69.    Ukraine cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 70.    Ukraine cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 71.    Ukraine cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 72.    Ukraine cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 73.    Poland cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 74.    Poland cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 75.    Poland cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 76.    Poland cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 77.    Poland cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 78.    Poland cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 79.    Switzerland cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 80.    Switzerland cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 81.    Switzerland cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 82.    Switzerland cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 83.    Switzerland cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 84.    Switzerland cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 85.    Belgium cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 86.    Belgium cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 87.    Belgium cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 88.    Belgium cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 89.    Belgium cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 90.    Belgium cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 91.    Greece cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 92.    Greece cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 93.    Greece cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 94.    Greece cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 95.    Greece cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 96.    Greece cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 97.    Czech Republic cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 98.    Czech Republic cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 99.    Czech Republic cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 100.    Czech Republic cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 101.    Czech Republic cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 102.    Czech Republic cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 103.    Netherlands cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 104.    Netherlands cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 105.    Netherlands cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 106.    Netherlands cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 107.    Netherlands cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 108.    Netherlands cell line development market, by application, 2013 - 2024 (USD Mn)
TABLE 109.    Sweden cell line development market, by product, 2013 - 2024 (USD Mn)
TABLE 110.    Sweden cell line development market, by equipment, 2013 - 2024 (USD Mn)
TABLE 111.    Sweden cell line development market, by source, 2013 - 2024 (USD Mn)
TABLE 112.    Sweden cell line development market, by non-mammalian source 2013 - 2024 (USD Mn)
TABLE 113.    Sweden cell line development market, by type of cell lines, 2013 - 2024 (USD Mn)
TABLE 114.    Sweden cell line development market, by application, 2013 - 2024 (USD Mn)

Charts & Figures
FIG 1.    Industry segmentation
FIG 2.    Europe cell line development market, 2013 - 2024 (USD Million)
FIG 3.    Growth potential analysis, by product
FIG 4.    Growth potential analysis, by source
FIG 5.    Growth potential analysis, by cell line type
FIG 6.    Growth potential analysis, by application
FIG 7.    Strategy dashboard
FIG 8.    Porter’s analysis
FIG 9.    PESTEL analysis
 


Select License

Europe Cell Line Development Market by Product, Source, Application


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media